Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas - PubMed (original) (raw)
Affiliations
- PMID: 7678574
Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas
S Y Peng et al. Hepatology. 1993 Jan.
Abstract
The messenger RNA and DNA methylation of the alpha-fetoprotein gene were studied in 101 resected primary hepatocellular carcinomas, of which 93 were unicentric and 8 were multicentric. Fifty-five were 5 cm or less in diameter (small) and 46 were more than 5 cm in diameter (large). In 48.5% of the cases, we detected alpha-fetoprotein messenger RNA in hepatocellular carcinomas, more frequently in large (60.9%) than in small (38.2%; p < 0.00001) but not in any of the nontumorous livers. The alpha-fetoprotein messenger RNA was detected in 83%, 70% and 6.8% of patients with serum alpha-fetoprotein levels of 320 ng/ml or more, 100 to 319 ng/ml and less than 100 ng/ml, respectively. This finding suggests that alpha-fetoprotein gene expression in hepatocellular carcinoma contributes to the serum alpha-fetoprotein elevation in patients with hepatocellular carcinoma. alpha-Fetoprotein messenger RNA appeared as a major band of 2.4 kb, with two minor species of about 6.5 and 3.6 kb in the hepatocellular carcinoma and the fetal liver. Hypomethylation of the 5' end of the alpha-fetoprotein gene was detected in 78.3% of hepatocellular carcinomas expressing alpha-fetoprotein messenger RNA but infrequently (16.7%) in hepatocellular carcinomas with no detectable alpha-fetoprotein messenger RNA (p < 0.0003). This finding suggests that hypomethylation at the 5' region of the gene is associated with alpha-fetoprotein gene reexpression in hepatocellular carcinoma. The alpha-fetoprotein gene expression helped to differentiate unicentric from multicentric hepatocellular carcinomas and to identify other hidden alpha-fetoprotein-secreting hepatocellular carcinomas.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S, Nakatsukasa H, Higashi T, Ashida K, Nouso K, Ishizaki M, Hino N, Kobayashi Y, Uematsu S, Tsuji T. Ohguchi S, et al. Hepatology. 1998 Feb;27(2):599-607. doi: 10.1002/hep.510270239. Hepatology. 1998. PMID: 9462663 - Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
Mitsuhashi N, Kobayashi S, Doki T, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Takeuchi D, Suda K, Miura S, Miyazaki M. Mitsuhashi N, et al. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e189-97. doi: 10.1111/j.1440-1746.2008.05340.x. Epub 2008 May 7. J Gastroenterol Hepatol. 2008. PMID: 18466288 - Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Niwa Y, Matsumura M, Shiratori Y, Imamura M, Kato N, Shiina S, Okudaira T, Ikeda Y, Inoue T, Omata M. Niwa Y, et al. Hepatology. 1996 Jun;23(6):1384-92. doi: 10.1053/jhep.1996.v23.pm0008675155. Hepatology. 1996. PMID: 8675155 - Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
Chang YC, Dai YC, Chow NH. Chang YC, et al. Hepatogastroenterology. 2003 Sep-Oct;50(53):1637-40. Hepatogastroenterology. 2003. PMID: 14571804 Review. - [Structure and expression of alpha-fetoprotein gene--current progress in research].
Tamaoki T. Tamaoki T. Gan To Kagaku Ryoho. 1983 Feb;10(2 Pt 2):623-30. Gan To Kagaku Ryoho. 1983. PMID: 6192763 Review. Japanese.
Cited by
- Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma.
Li W, Cai HX, Ge XM, Li K, Xu WD, Shi WH. Li W, et al. Tumour Biol. 2013 Apr;34(2):669-74. doi: 10.1007/s13277-012-0594-x. Epub 2012 Nov 23. Tumour Biol. 2013. PMID: 23179403 - High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
Hu BS, Zhao G, Yu HF, Chen K, Dong JH, Tan JW. Hu BS, et al. Tumour Biol. 2013 Feb;34(1):271-6. doi: 10.1007/s13277-012-0547-4. Epub 2012 Oct 5. Tumour Biol. 2013. PMID: 23055200 - High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M. Zhang Y, et al. Pathol Oncol Res. 2013 Jan;19(1):79-88. doi: 10.1007/s12253-012-9560-6. Epub 2012 Sep 12. Pathol Oncol Res. 2013. PMID: 22965687 - Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.
Jiang C, Zhang Y, Yu HF, Yu XT, Zhou SJ, Tan YF. Jiang C, et al. Tumour Biol. 2012 Dec;33(6):2167-72. doi: 10.1007/s13277-012-0477-1. Epub 2012 Sep 1. Tumour Biol. 2012. PMID: 22941466 Clinical Trial. - Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?
Hsieh CB, Chen TW, Chu CM, Chu HC, Yu CP, Chung KP. Hsieh CB, et al. World J Gastroenterol. 2010 Jun 28;16(24):3049-55. doi: 10.3748/wjg.v16.i24.3049. World J Gastroenterol. 2010. PMID: 20572309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical